Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Cancer Vaccines Show Promise. But We Have More Work to Do.

(MedPage Today) -- The controversy surrounding the premature disclosure of Moderna and Merck's mRNA melanoma vaccine results risks overshadowing a more consequential clinical discussion: how individualized cancer vaccines might fit into an increasingly...

Cancer Vaccines Show Promise. But We Have More Work to Do.

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

HIV-Blocking Antibody Shows Promise, but Resistant Strains Break Through

A new study finds that the VRC01 antibody initially protects against HIV infection, but resistant strains can cause breakthrough infections as antibody levels decline, highlighting the need for…

  • Intravenous VRC01 antibody targets HIV-1 envelope glycoprotein
  • VRC01 provided 66.3% protection against sensitive strains
  • Resistant strains emerged post-treatment leading to breakthrough infections

More from Wednesday 4 November →